Roche's Gazyvaro Receives Backing of EU's CHMP for CLL
EU's Committee for Medicinal Products for Human Use (CHMP)supported the use of Gazyvaro based on the phase III CLL11 study, wherein treatment with Gazyvaro (obinutuzumab) plus chlorambucil significantly reduced the risk of disease worsening or death by 86% and increased survival time for previously untreated CLL patients compared to those who received treatment with chlorambucil alone.
3 Pathways to Patient-Centered Care
A new report highlights the ways hospitals can identify and address sources of "avoidable suffering" and ultimately improve the patient experience.
EHR Adoption Increases 133% at Community Health Centers
Federally qualified health centers (FQHCs) have increased their EHR adoption by 133% over the past four years, says a report from The Commonwealth Fund, with 93% of FQHCs in possession of an EHR and 85% of these community provider organizations reporting advanced HIT capabilities.
Medical Homes, ACOs Offer Better Business Models
The patient-centered medical home model in Arkansas, which has more than 600 participating providers, helps the state's Medicaid program incentivize quality care instead of paying for volume of services.
Geneticists on Both Coasts Issue 'Call to Action' On Need to Share DNA Data
In the new issue of Evidence-Based Oncology, Ellen T. Matloff, MS, CGC, and Rachel E. Barnett, MS, CGC, of the Yale Cancer Center and Robert Nussbaum, MD, of UC San Francisco write that efforts by some genetic testing laboratories to grab market share in the lucrative BRCA testing market may put patients at risk, while violating ethical standards issued by the American Medical Association.
2013 Volume 19 Number SP11
Bundled Payments Could Cut Medicare Fraud, Experts Say
Health and policy experts are pushing for a system that pays doctors a lump sum for medical care or allows them to share in savings, saying it will save millions of dollars over current fee-for-service payments that can lead to fraud and over-use of medications.
States Stick to Insurance Exchange Models
Few states could claim Obamacare's first enrollment period was smooth-whatever the final numbers-but most will approach their insurance exchanges the same way for the 2015 window. None has asked the Obama administration to take over its marketplace or elected to abandon HealthCare.gov in favor of running its own.